Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01208727
Other study ID # 2008-504
Secondary ID
Status Completed
Phase N/A
First received September 23, 2010
Last updated May 7, 2013
Start date April 2009
Est. completion date March 2011

Study information

Verified date September 2010
Source Hospices Civils de Lyon
Contact n/a
Is FDA regulated No
Health authority France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)
Study type Interventional

Clinical Trial Summary

After having shown that postconditioning allowed a significant 36% reduction of infarct size as assessed by blood levels of myocardial enzymes in acute myocardial patients, the investigators objective is to assess the effect of postconditioning in acute myocardial infarction (AMI) patients on microvascular obstruction lesions defined by cardiac MRI images.


Recruitment information / eligibility

Status Completed
Enrollment 44
Est. completion date March 2011
Est. primary completion date April 2009
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patients > 18 years old,

- Male or female,

- Presenting first myocardial infarction, with the beginning of pains < 12 hours,

- Requiring a revascularisation by primary angioplasty or " rescue " (after failure of thrombolysis) on IVA or RCA (not CA).

- Artery guilty with TIMI flow = 0

Exclusion Criteria:

- cardiac arrest before the angioplasty,

- Cardiogenic shock

- Occlusion of the artery circumflex responsible for the infarction

- Magnetic resonance imaging: contre indication

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Intervention

Procedure:
postconditioning
Direct postconditioning (brief repeated cycle of 4 occlusion and desocclusion of the initially occluded culprit coronary artery) after primary direct stenting.

Locations

Country Name City State
France Hospices Civils de Lyon Lyon

Sponsors (1)

Lead Sponsor Collaborator
Hospices Civils de Lyon

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Extent of the area of microvascular obstruction Extent of the area of microvascular obstruction defined on post-gadolinium CMR images realized 48-72 hours after admission in each group 5 days Yes
Secondary Size of the myocardial infarction Size of the myocardial infarction defined on post-gadolinium CMR images realized 48-72 hours after admission in each group. 5 days Yes
See also
  Status Clinical Trial Phase
Recruiting NCT00989508 - Myocardial Protection With Perhexiline in Left Ventricular Hypertrophy Phase 2/Phase 3
Not yet recruiting NCT04570514 - Optimized Cardioprotection Therapy in Obese Subjects With AMI
Active, not recruiting NCT01857414 - Effect of RIC on Clinical Outcomes in STEMI Patients Undergoing pPCI N/A
Completed NCT02342522 - Effect of Remote Ischaemic Conditioning on Clinical Outcomes in STEMI Patients Undergoing PPCI (CONDI2/ERIC-PPCI) N/A
Active, not recruiting NCT05462730 - Pulse Glucocorticoid Therapy in Patients With ST-Segment Elevation Myocardial Infarction Phase 2
Completed NCT04397939 - Myocardial Injury and Major Adverse Outcomes in Patients With COVID-19
Withdrawn NCT02098629 - Concomitant Milrinone and Esmolol Treatment in Patients With Acute Myocardial Infarction Phase 1/Phase 2
Completed NCT00586820 - Role of Endothelin in Microvascular Dysfunction Following PCI for NSTEMI Phase 2
Completed NCT02390674 - Ciclosporin to Reduce Reperfusion Injury in Primary PCI Phase 2
Completed NCT00865722 - Remote Postconditioning in Patients With Acute Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention (PCI) Phase 2/Phase 3
Recruiting NCT01307371 - Cell Therapy in Diabetic Patients With ST-Segment Elevation Myocardial Infarction(STEMI) Phase 1
Completed NCT01379261 - Efficacy of Endovascular Catheter Cooling Combined With Cold Saline for the Treatment of Acute Myocardial Infarction Phase 2/Phase 3
Completed NCT00881686 - Myocardial Protection With Adenosine Preconditioning Phase 1/Phase 2
Completed NCT00484575 - Inhaled Sevoflurane Compared to Intravenous Sedation Post Coronary Artery Bypass Grafting Phase 1/Phase 2
Recruiting NCT03995732 - Efficacy and Safety Evaluation of PC-SOD for Injection in Reducing Myocardial Reperfusion Injury Phase 2
Recruiting NCT05775380 - The Role of Pioglitazone in Vascular Transcriptional Remodeling Phase 4
Completed NCT06450912 - Wall Strain Index Ratio as a Biomarker for Mechanical Complication of Hemorrhagic Myocardial Infarction
Completed NCT05354648 - Effects of Hypoxic-hyperoxic Preconditioning in Cardio-surgical Patients N/A
Completed NCT01601795 - Sevoflurane and Isoflurane - During Cardiopulmonary Bypass With the MECC System (Minimized Extracorporeal Circuit) Phase 4
Completed NCT01354808 - ACCEL-LOADING-ACS Study Phase 4